Makarova Maria, Krettek Alexandra, Valkov Mikhail Y, Grjibovski Andrej M
International School of Public Health, Northern State Medical University, Arkhangelsk, Russia.
Int J Circumpolar Health. 2013 May 13;72:20282. doi: 10.3402/ijch.v72i0.20282. Print 2013.
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The prevalence of hepatitis B (HBV) and C (HCV) in Russia was 7.6 and 5.4 per 100,000, respectively. The aim of this study was to assess the proportion of HCV and HBV infection among HCC patients, to evaluate associations between HCV, HBV and stage of HCC and to compare survival of HCC patients by their HBV/HCV status in the Arkhangelsk region of northwest Russia.
A retrospective cohort study was conducted using data on all histologically confirmed HCC cases. Proportions of infected and non-infected HCC cases were calculated by Wilson's method. The associations between HBV, HCV and severity of HCC were assessed by Pearson's Chi-squared test. Survival data were presented using Kaplan-Meier curves and median survival. Survival time between the groups was compared using log-rank tests. Adjustment for potential confounders (sex, age groups, stage of HCC and cirrhosis stage by Child-Paquet scale) was performed using Cox regression.
There were 583 histologically confirmed HCC cases. The viral status was registered in 311 of patients with pre-mortem diagnosis, where 124 or 39.9% (95% confidence interval (CI), 34.4-45.4) had HBV, 54 or 17.4% (95% CI, 13.5-21.9) had HCV and 16 or 5.1% (95% CI, 3.2-8.2) were infected with both HBV and HCV. The median survival rates of patients were 3 months (95% CI, 2.3-3.8), 3 months (95% CI, 2.0-3.9) and 1 month (95% CI, 0.0-0.6) for patients with HBV, HCV and HBV and HCV, respectively. For virus-free patients, it was 5 months (95% CI, 3.5-6.5), log-rank test=10.74, df=3, p=0.013. Crude Cox regression showed increased risk of death for HBV and HBV and HCV groups in comparison with virus-free patients, and not reaching the level of statistical significance for HCV. After adjustment, the hazard ratios (HRs) decreased to non-significant levels or even reversed, with only exception for the group of patients infected with both hepatitis viruses.
We found that more than half of HCC patients were infected with HBV or HCV. The study did not reveal an association between viral status of HCC patients and stage of HCC. The viral hepatitis may have an impact on survival of HCC patients.
肝细胞癌(HCC)是全球最常见的癌症之一。俄罗斯乙型肝炎(HBV)和丙型肝炎(HCV)的患病率分别为每10万人7.6例和5.4例。本研究的目的是评估HCC患者中HCV和HBV感染的比例,评估HCV、HBV与HCC分期之间的关联,并比较俄罗斯西北部阿尔汉格尔斯克地区HCC患者按其HBV/HCV状态的生存率。
采用所有经组织学确诊的HCC病例数据进行回顾性队列研究。通过威尔逊法计算感染和未感染HCC病例的比例。采用Pearson卡方检验评估HBV、HCV与HCC严重程度之间的关联。生存数据用Kaplan-Meier曲线和中位生存期表示。采用对数秩检验比较组间生存时间。使用Cox回归对潜在混杂因素(性别、年龄组、HCC分期和Child-Paquet量表的肝硬化分期)进行调整。
有583例经组织学确诊的HCC病例。311例生前诊断患者登记了病毒状态,其中124例(39.9%,95%置信区间(CI),34.4 - 45.4)感染HBV,54例(17.4%,95%CI,13.5 - 21.9)感染HCV,16例(5.1%,95%CI,3.2 - 8.2)同时感染HBV和HCV。HBV、HCV以及HBV和HCV感染患者的中位生存率分别为3个月(95%CI,2.3 - 3.8)、3个月(95%CI,2.0 - 3.9)和1个月(95%CI,0.0 - 0.6)。无病毒感染患者的中位生存率为5个月(95%CI,3.5 - 6.5),对数秩检验=10.74,自由度=3,p = 0.013。粗Cox回归显示,与无病毒感染患者相比,HBV以及HBV和HCV感染组的死亡风险增加,但HCV组未达到统计学显著水平。调整后,风险比(HRs)降至非显著水平甚至逆转,仅同时感染两种肝炎病毒的患者组除外。
我们发现超过一半的HCC患者感染了HBV或HCV。该研究未揭示HCC患者的病毒状态与HCC分期之间的关联。病毒性肝炎可能对HCC患者的生存有影响。